This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here


May 11, 2011--Senomyx, Inc. (NASDAQ: SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that the Company has been granted U.S. Patent No. 7,939,671, which includes composition-of-matter claims for a family of Senomyx’s bitter blockers and their use in all forms of foods and beverages, as well as in medicaments and other products. The patent was issued on May 10, 2011 and will be in force until January 17, 2029.

“The broad scope of our new patent underscores the wide-ranging market opportunity for Senomyx’s bitter blockers,” said Kent Snyder, Chief Executive Officer of the Company. “These novel flavor ingredients can meet manufacturers’ needs by enabling a significant reduction in bitterness without altering other product properties. Senomyx’s bitter blockers could also allow manufacturers to forgo the use of masking agents or sweeteners to counter unwanted bitter tastes, which may provide both cost-of-goods and nutritional benefits.

“A notable aspect of the new patent is the large variety of product applications included in the claims,” Snyder stated. In addition to foods, beverages, and pharmaceuticals, the patent covers use of Senomyx’s bitter blockers to alleviate or eliminate bitter taste in food supplements, nutraceuticals, functional foods, over-the-counter medications, oral care, and other products. The patent also protects use of the bitter blockers in a variety of beverage formats such as ready-to-drink, concentrated, and instant formulations.

The newly issued patent includes specific claims directed to Senomyx’s S6821 bitter blocker, as well as other claims covering a large number of analogs, including S7958. Both S6821 and S7958, which have similar functionality with alternative desirable physical properties, received GRAS (Generally Recognized As Safe) regulatory designations in October 2010. The GRAS status allows the bitter blockers to be incorporated into a variety of product categories in the U.S. and multiple additional countries.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community


Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs